Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Mayo Clin Proc. 2018 Aug;93(8):980–990. doi: 10.1016/j.mayocp.2018.05.027

Table 2C.

Anti-HTN Drugs Prescribed in Subjects with Diagnosis of HTN Taking Three or More Drugs (n=45)

Drug Combination Frequencya Percentb
Beta Blocker + CCB + Diuretic 8 1.7
Beta Blocker + Ace Inhibitor + Diuretic 6 1.3
Diuretic + Vasodilator + ARB 4 0.8
Ace Inhibitor + Diuretic + Vasodilator 4 0.8
CCB + Diuretic + ARB 4 0.8
CCB + Ace Inhibitor + Diuretic 4 0.8
Beta Blocker + Diuretic + ARB 4 0.8
CCB + Diuretic + Vasodilator 3 0.6
CCB + Ace Inhibitor + Diuretic + Vasodilator 2 0.4
Beta Blocker + CCB + Ace Inhibitor 2 0.4
Beta Blocker + CCB + Ace Inhibitor + Diuretic 2 0.4
Beta Blocker + Ace Inhibitor + Diuretic + Vasodilator 1 0.2
Beta Blocker + CCB + Vasodilator 1 0.2
a

Frequency refers to number of subjects.

b

Percent is calculated on the total subjects with a diagnosis of hypertension. BB= beta blockers, CCB= calcium channel blockers, ACEI= angiotensin converting enzyme inhibitors, ARB= angiotensin II receptor blockers.